发明名称 POLYMORPHISM IN HUMAN MDR-1 GENE AND USE THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
摘要 <P>PROBLEM TO BE SOLVED: To provide general means and methods of diagnosing and treating the phenotypic spectrum as well as the overlapping clinical characteristics with several forms of inherited abnormal expression and/or function of the Multi Drug Resistance-1 (MDR-1) gene. <P>SOLUTION: There are provided the polynucleotide of a molecular variant MDR-1 gene which is associated with uptake of drugs by a target cell, and the vector comprising such the polynucleotide. Furthermore, the host cell comprising such the polynucleotide or vector and the use thereof for the production of variant MDR-1 proteins are also provided. In addition, the variant MDR-1 protein and the antibody specifically recognizing such the protein as well as the transgenic non-human animal comprising the polynucleotide or the vector are provided. The method for identifying and obtaining inhibitors for therapy of disorders related to the multifunction of the MDR-1 gene as well as the method for diagnosing the status of such disorders are provided. The method for diagnosing such the disease, and the pharmaceutical composition are also provided. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011142909(A) 申请公布日期 2011.07.28
申请号 JP20110011834 申请日期 2011.01.24
申请人 TROVIS PHARMACEUTICALS LLC 发明人 BRINKMANN ULRICH;HOFFMEYER SVEN;EICHELBAUM MICHEL;ROOTS IVAR
分类号 A01K67/027;C12N15/09;A61K31/436;A61K31/7088;A61K31/711;A61K35/12;A61K38/00;A61K39/395;A61K45/00;A61K48/00;A61P9/00;A61P9/04;A61P25/00;A61P25/08;A61P31/04;A61P35/00;A61P37/06;A61P43/00;C07K14/47;C07K14/705;C07K16/18;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/00;C12N15/11;C12N15/12;C12P21/02;C12Q1/02;C12Q1/06;C12Q1/68;G01N33/15;G01N33/50;G01N33/53;G01N33/566 主分类号 A01K67/027
代理机构 代理人
主权项
地址